Ebola vaccine trial shows promising results
The first Ebola vaccine to be tested on humans, developed by GlaxoSmithKline and the US National Institutes of Health, has shown promising results in early trials, paving the way for it to be tested on healthcare workers in west Africa in the new year. Fiona Symon spoke to Andrew Ward about the potential of the vaccine to address the Ebola crisis
See acast.com/privacy for privacy and opt-out information.
